looks like market is going through a little correction. lets see how HLO holds up. if it manages to hold up well then i may enter as it shows its bullish but if it tumbles then i may wait for a better opportunity. i think the US market will continue a downward trend from here and the ASX will follow. time will tell, all IMO
- Forums
- ASX - By Stock
- HLO
- Ann: HLO Trading Update for March Quarter 2024
Ann: HLO Trading Update for March Quarter 2024, page-411
-
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.92 |
Change
0.000(0.00%) |
Mkt cap ! $309.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18 | $1.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.82 | 246 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1607 | 1.915 |
7 | 13623 | 1.910 |
4 | 3188 | 1.905 |
10 | 21789 | 1.900 |
1 | 1450 | 1.895 |
Price($) | Vol. | No. |
---|---|---|
1.925 | 1322 | 3 |
1.930 | 4241 | 7 |
1.935 | 4495 | 7 |
1.940 | 1570 | 2 |
1.945 | 7082 | 5 |
Last trade - 09.50am 11/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
HLO (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online